What will the closing price of International Business Machines Corporation (IBM) common stock be on December 31, 2026?

rationale:

Current Setup and Recent Crash As of late August 2026, IBM common stock is trading near $236 with a market cap of roughly $222B stockanalysis.com. The premise that IBM has been a "strong performer" in 2026 is structurally outdated. On July 14, 2026, IBM pre-announced weak preliminary Q2 results, triggering a ~25% single-day collapse—the worst in the company's 115-year history stockanalysis.com. Full Q2 results on July 22 confirmed this weakness, largely driven by a 42% plunge in Z mainframe revenue and delayed transaction-processing software deals, as clients redirected budgets toward AI infrastructure cnbc.com. Management consequently cut full-year constant-currency revenue growth guidance from >5% to 4–5%, though they reiterated ~$1B in free-cash-flow growth cnbc.com.

Market Sentiment and Analyst Reset Following the Q2 disappointment, analyst consensus was reset sharply lower, with targets now mostly clustering in the $245 to $265 range 3 sources. A raft of post-crash target cuts—including Morgan Stanley to $190, Susquehanna to $225, and Citi to $245—reflects a firm "show-me" sentiment across the market marketbeat.com. Investors will require definitive proof of execution before multiple expansion can occur. Given the credibility-damaging miss, 12-month sell-side targets are best viewed as systematically optimistic, making it prudent to anchor expectations closer to current spot prices rather than assuming mean reversion to pre-crash levels.

Volatility-Based Baseline The forecast distribution is mathematically grounded in current market pricing and option-implied volatility. IBM’s 30-day implied volatility sits at approximately 33%, with the January 2027 straddle implying an expected move of roughly ±18.6% 2 sources. Scaling this to the ~4.3-month horizon through December 31 yields a one-standard-deviation move of about 17–18%. Anchoring the median at $238—slightly above the spot price—accounts for mild equity drift, which is offset by one expected ~$1.69 quarterly dividend ex-date in November stockanalysis.com and persisting headline risks from securities-fraud investigations tied to the July drop stockanalysis.com.

Catalysts and Tail Risks The primary catalyst before resolution is Q3 earnings on October 21, 2026 ibm.com. The distribution maintains a fat left tail (p10 of $190.0) to account for structural risks: if Q3 results suggest that enterprise AI adoption is genuinely cannibalizing IBM's legacy software and consulting franchises, or if another guidance cut materializes, shares could easily test the $190s or lower. Conversely, the right tail (p90 of $288.0) accommodates a scenario where Q3 confirms that the Q2 deal delays were purely timing-related and IBM Z sales re-accelerate, potentially driving a sharp re-rating toward the pre-crash highs. Evaluating this alongside broader US macroeconomic and equity index trajectories supports a slight narrowing of the extreme price tails to reflect a highly probable choppy, range-bound market through late 2026. Broader macro factors, particularly uncertain Fed monetary policy amid elevated inflation, add correlated two-sided event risk to the multiple federalreserve.gov.